YcgC represents a new protein deacetylase family in prokaryotes.

shihte tu,Shu-Juan Guo,Chien-Sheng Chen,chun xiao liu,He-Wei Jiang,Feng Ge,Jiao-Yu Deng,Yi-Ming Zhou,Daniel M Czajkowsky,yousheng li,Bang-Ruo Qi,Young-Hoon Ahn,Philip A Cole,hongbo zhu,Sheng-Ce Tao
DOI: https://doi.org/10.7554/eLife.05322
IF: 7.7
2015-01-01
eLife
Abstract:Reversible lysine acetylation is one of the most important protein posttranslational modifications that plays essential roles in both prokaryotes and eukaryotes. However, only a few lysine deacetylases (KDACs) have been identified in prokaryotes, perhaps in part due to their limited sequence homology. Herein, we developed a clip-chip strategy to enable unbiased, activity-based discovery of novel KDACs in the Escherichia coli proteome. In-depth biochemical characterization confirmed that YcgC is a serine hydrolase involving Ser200 as the catalytic nucleophile for lysine deacetylation and does not use NAD(+) or Zn2(+) like other established KDACs. Further, in vivo characterization demonstrated that YcgC regulates transcription by catalyzing deacetylation of Lys52 and Lys62 of a transcriptional repressor RutR. Importantly, YcgC targets a distinct set of substrates from the only known E. coli KDAC CobB. Analysis of YcgCs bacterial homologs confirmed that they also exhibit KDAC activity. YcgC thus represents a novel family of prokaryotic KDACs.
What problem does this paper attempt to address?